End-of-day quote
Shanghai S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
30.54
CNY
|
+4.05%
|
|
+12.78%
|
-33.61%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,355
|
1,279
|
2,936
|
3,090
|
2,832
|
3,429
|
Enterprise Value (EV)
1 |
1,520
|
1,450
|
3,044
|
3,093
|
2,853
|
3,596
|
P/E ratio
|
35.6
x
|
-22.3
x
|
-60.6
x
|
-57.6
x
|
-168
x
|
-77.2
x
|
Yield
|
0.88%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.38
x
|
2.77
x
|
9.43
x
|
24.1
x
|
21.9
x
|
14.3
x
|
EV / Revenue
|
2.67
x
|
3.14
x
|
9.78
x
|
24.1
x
|
22
x
|
15
x
|
EV / EBITDA
|
23.3
x
|
-45.4
x
|
-94.8
x
|
-74.8
x
|
-99.9
x
|
-435
x
|
EV / FCF
|
-11.3
x
|
50.1
x
|
39.9
x
|
24.5
x
|
-92.2
x
|
-56.6
x
|
FCF Yield
|
-8.84%
|
2%
|
2.51%
|
4.07%
|
-1.08%
|
-1.77%
|
Price to Book
|
2.75
x
|
3.05
x
|
7.91
x
|
9.73
x
|
9.42
x
|
13.4
x
|
Nbr of stocks (in thousands)
|
74,535
|
74,535
|
74,535
|
74,535
|
74,535
|
74,535
|
Reference price
2 |
18.18
|
17.16
|
39.39
|
41.46
|
38.00
|
46.00
|
Announcement Date
|
3/5/19
|
4/28/20
|
4/26/21
|
4/26/22
|
4/26/23
|
4/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
569.8
|
461.9
|
311.3
|
128.1
|
129.5
|
239.4
|
EBITDA
1 |
65.19
|
-31.94
|
-32.1
|
-41.38
|
-28.56
|
-8.259
|
EBIT
1 |
53.77
|
-43.53
|
-45.43
|
-54.06
|
-41.4
|
-22.6
|
Operating Margin
|
9.44%
|
-9.42%
|
-14.59%
|
-42.19%
|
-31.96%
|
-9.44%
|
Earnings before Tax (EBT)
1 |
43.41
|
-57.9
|
-52.78
|
-55.62
|
-21.28
|
-34.83
|
Net income
1 |
38.01
|
-57.05
|
-48.08
|
-53.43
|
-16.82
|
-44.42
|
Net margin
|
6.67%
|
-12.35%
|
-15.44%
|
-41.7%
|
-12.99%
|
-18.55%
|
EPS
2 |
0.5100
|
-0.7700
|
-0.6500
|
-0.7200
|
-0.2256
|
-0.5960
|
Free Cash Flow
1 |
-134.4
|
28.95
|
76.27
|
126
|
-30.95
|
-63.58
|
FCF margin
|
-23.58%
|
6.27%
|
24.5%
|
98.35%
|
-23.89%
|
-26.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1600
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/5/19
|
4/28/20
|
4/26/21
|
4/26/22
|
4/26/23
|
4/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
165
|
171
|
108
|
2.89
|
20.6
|
168
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.525
x
|
-5.358
x
|
-3.363
x
|
-0.0699
x
|
-0.7202
x
|
-20.3
x
|
Free Cash Flow
1 |
-134
|
28.9
|
76.3
|
126
|
-30.9
|
-63.6
|
ROE (net income / shareholders' equity)
|
7.97%
|
-12.6%
|
-12.2%
|
-15.5%
|
-5.44%
|
-13%
|
ROA (Net income/ Total Assets)
|
4.65%
|
-3.62%
|
-4.5%
|
-6.75%
|
-6.22%
|
-2.81%
|
Assets
1 |
817.2
|
1,577
|
1,068
|
791.5
|
270.6
|
1,579
|
Book Value Per Share
2 |
6.600
|
5.620
|
4.980
|
4.260
|
4.040
|
3.440
|
Cash Flow per Share
2 |
0.8100
|
0.2500
|
0.1300
|
0.7000
|
0.3800
|
0.4500
|
Capex
1 |
41.4
|
15.8
|
0.38
|
0.39
|
-
|
0.25
|
Capex / Sales
|
7.26%
|
3.42%
|
0.12%
|
0.31%
|
-
|
0.1%
|
Announcement Date
|
3/5/19
|
4/28/20
|
4/26/21
|
4/26/22
|
4/26/23
|
4/18/24
|
|
1st Jan change
|
Capi.
|
---|
| -33.61% | 302M | | +11.76% | 63.22B | | -3.51% | 46.34B | | +13.09% | 39.97B | | +19.99% | 25.46B | | +8.37% | 18.68B | | +1.44% | 17.24B | | -20.33% | 15.81B | | +0.36% | 14.9B | | -12.98% | 13.74B |
Other Specialty Chemicals
|